Human Gene Module / Chromosome 6 / DOP1A

DOP1ADOP1 leucine zipper like protein A

SFARI Gene Score
3
Suggestive Evidence Criteria 3.1
Autism Reports / Total Reports
7 / 8
Rare Variants / Common Variants
15 / 0
Aliases
-
Associated Syndromes
-
Chromosome Band
6q14.1
Associated Disorders
-
Relevance to Autism

Ariyama et al., 2026 identified 11 patients from 8 families with either de novo heterozygous or homozygous variants in DOP1A presenting with neurodevelopmental phenotypes, including developmental delay in all individuals and intellectual disability in 8 individuals, as well as autistic features in 4 individuals and sterotypic behavior in two others; in the same report, the authors observed behavioral abnormalities, including impaired discrimination of novel and familiar mice in the 3-chamber social interaction assay, in both Dop1a knockout mice and mice harboring a patient-derived p.Arg355Cys variant. De novo variants in DOP1A, including a de novo loss-of-function variant and four de novo missense variants, have been identified in ASD probands from the SPARK cohort, the Autism Sequencing Consortium, and a Chinese ASD cohort (Zhou et al., 2022; Fu et al., 2022; Trost et al., 2022; Wang et al., 2023; Tan et al., 2025).

Molecular Function

Predicted to be involved in Golgi to endosome transport and endoplasmic reticulum organization. Predicted to be located in Golgi membrane. Predicted to be active in endosome and trans-Golgi network. Ariyama et al., 2026 recently demonstrated that Dop1a regulates nuclear phospholipid homeostatis under the control of mTOR signaling, and that loss of Dop1a resulted in neural cell overgrowth and compromised neural development in mice.

SFARI Genomic Platforms
Reports related to DOP1A (8 Reports)
# Type Title Author, Year Autism Report Associated Disorders
1 Support - Shi, Lingling et al. (2013) Yes -
2 Support Whole genome sequencing and variant discovery in the ASPIRE autism spectrum disorder cohort Callaghan DB , et al. (2019) Yes -
3 Support - Zhou X et al. (2022) Yes -
4 Support - Fu JM et al. (2022) Yes -
5 Support - Trost B et al. (2022) Yes -
6 Support - Wang J et al. (2023) Yes -
7 Support - Senwei Tan et al. () Yes -
8 Primary - Ariyama, Hirotaka et al. (2026) No Autistic features, stereotypy
Rare Variants   (15)
Status Allele Change Residue Change Variant Type Inheritance Pattern Parental Transmission Family Type PubMed ID Author, Year
G>C - splice_site_variant De novo - Simplex 39472663 Senwei Tan et al. ()
c.173C>A p.Pro58His missense_variant De novo - - 35982160 Fu JM et al. (2022)
c.6940C>T p.Arg2314Ter stop_gained Unknown - - 31038196 Callaghan DB , et al. (2019)
c.411T>G p.Gly137= synonymous_variant De novo - Simplex 35982159 Zhou X et al. (2022)
c.1399T>A p.Leu467Ile missense_variant De novo - Simplex 37393044 Wang J et al. (2023)
c.7129G>A p.Gly2377Ser missense_variant De novo - Simplex 35982159 Zhou X et al. (2022)
c.3682G>A p.Val1228Met missense_variant De novo - Simplex 36368308 Trost B et al. (2022)
c.6119T>G p.Leu2040Ter stop_gained De novo - Simplex 42164854 Ariyama, Hirotaka et al. (2026)
c.7241G>A p.Arg2414Gln missense_variant Familial - Multiplex 23597238 Shi, Lingling et al. (2013)
c.1063C>T p.Arg355Cys missense_variant De novo - Simplex 42164854 Ariyama, Hirotaka et al. (2026)
c.5977C>T p.Arg1993Ter stop_gained Familial Both parents Multiplex 42164854 Ariyama, Hirotaka et al. (2026)
c.1234_1238del p.Asn412GlufsTer7 frameshift_variant De novo - Simplex 42164854 Ariyama, Hirotaka et al. (2026)
c.4093_4096del p.Leu1365IlefsTer27 frameshift_variant De novo - Simplex 42164854 Ariyama, Hirotaka et al. (2026)
c.2894G>T p.Ser965Ile missense_variant Familial Both parents Multiplex 42164854 Ariyama, Hirotaka et al. (2026)
c.5368_5369del p.Ile1790CysfsTer10 frameshift_variant De novo - Multiplex 42164854 Ariyama, Hirotaka et al. (2026)
Common Variants  

No common variants reported.

SFARI Gene score
3

Suggestive Evidence

3

Suggestive Evidence

See all Category 3 Genes

The literature is replete with relatively small studies of candidate genes, using either common or rare variant approaches, which do not reach the criteria set out for categories 1 and 2. Genes that had two such lines of supporting evidence were placed in category 3, and those with one line of evidence were placed in category 4. Some additional lines of "accessory evidence" (indicated as "acc" in the score cards) could also boost a gene from category 4 to 3.

4/1/2026
3

Initial score established: 3

Submit New Gene

Report an Error